HEALTHWTOP DC
FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers
An FDA panel narrowly voted 8-6 to allow compounding pharmacies to produce BPC-157, a popular unapproved peptide promoted by influencers like Joe Rogan. The decision followed criticism from FDA scientists about the lack of evidence for its medical efficacy, while panel members included individuals with industry ties. Health Secretary Robert F. Kennedy Jr. supported the move, aiming to overturn Biden-era restrictions.
Mentioned
Related Signal
Adjacent reporting
- FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.